When GILD puts a price on a drug and then zeroes out part of patients' co-pays, then isn't the price of the drug really lowered? When the reduction doesn't include Medicare patients, is Medicare likely to insist on the same or a similar price reduction? Will insurance companies limit use of the drug? I hope that people who want the drug to bring in more and more revenue realize that insurance companies that we want to keep premiums as low as possible may need to raise rates.
How much value has the exiting officer taken out of the company and away from retail longs? Is this a sign that the shares handed out to employees now won't reap the profits that selling such shares has in the past?
Thank you for asking. Actually, I went long HUM from it's dip under 95 and exited Friday, the last market day before the end of the Medicare open season. Though I'd been out of CELG for awhile, I scalped it twice last week as it went from bounces over 66 to under 66 and then took a tiny long position, which I closed out this morning. I don't have a position in CELG. It's possible this morning's bounce in CELG was the top, but while news comes out, I'll stand aside from CELG.
Regarding CRM, it is trading uinder the 50 day MA and I remain negative about CRM. During 2013 a good part of CELG's and other companies' increases were due to stock buybacks. That action doesn't apply to CRM. In fact, CRM has added stock and that is bearish, IMHO.
When I see multiple overbought positions in one sentence (my only position in any of those is in CRM) I see irony. I don't know if it's intentional, but none of the above is a long at this time. I see a list of stocks that were once longs, but aren't now, IMHO. By Icahn, I don't know if you are refering to the position in his name or positions he has held recently.
One institutional holder may try to keep it up, but another institutional holder or hedge fund manager appears to sell or short on each bounce.
Are you delusional? I haven't even looked at AZO in years. As of then, AZO was buying stock back and there appeared to be financial engineering, as would be expected. I stayed away from SHLD and AZO ---same CEO. You love making accusations, even when you know they are ridiculous. Actually, maybe it's that you know or should know the accusations are ridiculous,, but it's your way of getting your "kicks." Not to worry, someone will have you banned from posting soon.
When a patent ends, there can be generics. Would GILD have to lower their anticipated prices to compete?
It's not cheaper and if insurers won't pay more of the cost, patients would have to pay more or not use the drug.
The auto industry includes suppliers. The direct employees of GM, Ford, Chrysler, etc. are only part of the auto industry. Many suppliers would have had to go out of business if there was no GM to supply since GM is a large buyer of supplies. It would also have jeopardized U.S. security.
Maybe he didn't pay attention to arithmetic in school, because it's apparent he didn't pay attention to grammar, etc..
Who raised it? You? I haven't traded ADBE for a long time, but based on the statistics I see, there's no real earnings that match the prior quarter's revenues. I also see an increase in Goodwill. I've seen this type of pattern in stocks about to go down, but will probably wait until tomorrow to evaluate ADBE. I do know that I won't be buying this up here. ADBE was once a nice buy, but is overpriced, IMHO.
First, some tech customers would rather not have subscriptions according to an article I read earlier this week (yesterday or the day before). Second, the lure of a subscription plan has been that an entire year's revenues can be counted at the onset of the subscriptions. It bites back later though. The a "plan" has enabled another company to increase revenues at first, but it didn't nothing for earnings. That company has zero GAAP earnings and actually continues to have GAAP losses. While it worked for awhile with that company (which is in a downtrend now), the dirty details are widely known now and is likely to not work.
I intend to look at ADBE in the morning. Based on the after hours numbers, ADBE has jumped from being under the 50 DMA to above the 50 DMA. Since tomorrow is Friday I likely won't start a position. It will be interesting to see if there is active institutional selling, especially if ADBE opens near or above the after hours ADBE trades.
I had expected CRM to give me a negative bottom line today, but my bottom line is positive. I've closed out my CRM options positions now, but continue to hold my CRM core shorted stock position.
Will there be shenanigans by the end of today?